Comparative Study Between Rezum Therapy in Small and Large Prostates

Four-year Follow-up in Rezum Therapy of Small Prostates in Comparison with Large Prostates. a Prospective Trial

The investigators aimed to compare the efficacy and safety of Rezūm therapy for the management of benign prostatic hyperplasia (BPH) in small and large prostates.

For decades, Transurethral resection of the prostate (TURP) was the gold standard surgical intervention for small and moderate prostates, however it has high morbidity and prolonged hospital stay Rezūm is a radiofrequency made water vapour thermal treatment. It has recently been added to the international guidelines as a choice for medical treatment resistant lower urinary tract symptoms (LUTS). The AUA and Canadian Urological Association (CUA) guidelines now add water vapour therapy as a treatment option for BPH patients with small prostate size <80 gm and for those wishing to maintain antegrade ejaculation. While investigators still offer no clear recommendation to Rezūm use for those with large prostates.

Inclusion Criteria:

1. prostate size 45-75 gm
2. sexually active
3. mod - sever LUTS
4. Q max < 15
5. IPSS > 15
6. failed medical treatment with alpha blockers

Exclusion Criteria:

1. neurogenic bladder
2. urethral stricture
3. UB stones
4. cancer prostate